Therapeutic area

Respiratory, thoracic and mediastinal disorders – page 100

1 274 clinical trials
444 recruiting
379 conditions
28 countries

Clinical trials in Respiratory, thoracic and mediastinal disorders

1 274 trials across Europe, recruiting first

Click a country to filter the trials

Quick filters

1 274 clinical trials

Lung disorder

Not recruiting

Registered drug

Study on Baricitinib for Hospitalized Patients with Severe or Critical COVID-19

Registered drug

Austria

Participants:18–64 years · 65+ years
Substances:Baricitinib
Sponsor:Oslo University Hospital HF

Contact Research Centre

Lung disorder

Not recruiting

Investigational

Study on the Effectiveness and Safety of Bemcentinib for Hospitalized Patients with Moderate COVID-19

Investigational

Belgium

Participants:18–64 years · 65+ years
Substances:Bemcentinib
Sponsor:Oslo University Hospital HF

Contact Research Centre

COVID-19

Not recruiting

Investigational

Study on Pamapimod and Pioglitazone for COVID-19 Recovery in Non-Hospitalized Patients

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Pamapimod
Sponsor:Kinarus AG

Contact Research Centre

Chronic obstructive pulmonary disease

Not recruiting

Registered drug

Study on Reducing Inhaled Corticosteroids and Using Azithromycin for Patients with Severe COPD

Registered drug

Denmark

Participants:18–64 years · 65+ years
Substances:Azithromycin
Sponsor:Frederiksberg Hospital

Contact Research Centre

Asthma

Not recruiting

Registered drugNo placebo

Study on Asthma Control and Adherence with Mepolizumab in Pre-filled Devices for Patients with Asthma

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Budesonide
Sponsor:Hospices Civils De Lyon

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study on Re-Challenging Advanced Lung Cancer with Cemiplimab After Initial Treatment with Ipilimumab and Radiotherapy

Registered drugNo placebo

The Netherlands

Participants:18–64 years
Substances:Cemiplimab
Sponsor:Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting

Contact Research Centre

Squamous cell carcinoma of head and neck+2

Not recruiting

InvestigationalNo placebo

Study of BGB-A425, LBL-007, and Tislelizumab for Patients with Advanced Head and Neck Cancer, Lung Cancer, or Kidney Cancer

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:Lbl-007
Sponsor:Beigene Ltd.

Contact Research Centre

Atrial fibrillation+2

Not recruiting

Registered drugNo placebo

Study on Dabigatran, Apixaban, Rivaroxaban, and Edoxaban for Patients with Atrial Fibrillation, Deep Vein Thrombosis, or Pulmonary Embolism

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Apixaban
Sponsor:Gentofte Hospital

Contact Research Centre

COVID-19

Not recruiting

Registered drugNo placebo

Study on Antiviral Therapy with Nirmatrelvir and Remdesivir for Immunocompromised COVID-19 Patients

Registered drugNo placebo

France

Participants:0–17 years · 18–64 years · 65+ years
Substances:Nirmatrelvir
Sponsor:Institut National De La Sante Et De La Recherche Medicale

Contact Research Centre

Pulmonary embolism+2

Not recruiting

Registered drugNo placebo

Study on Tinzaparin and Dalteparin for Patients with Venous Thromboembolism

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Dalteparin Sodium
Sponsor:Region Hovedstaden

Contact Research Centre

Non-small cell lung cancer+3

Not recruiting

Registered drugNo placebo

Study on Calcium Folinate to Reduce Pemetrexed Side Effects in Patients with Non-Small Cell Lung Cancer, Mesothelioma, or Thymoma

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Calcium Folinate
Sponsor:Amphia Hospital

Contact Research Centre

Pulmonary hypertension

Not recruiting

Investigational

Study on the Safety and Effectiveness of MK-5475 for Adults with Pulmonary Hypertension and COPD

Investigational

Austria

Participants:18–64 years · 65+ years
Substances:3-(4-{(5S)-4-Amino-2-[6-Chloro-1-(3,3,4,4,4-Pentafluorobutyl)-1H-Indazol-3-Yl]-5-Methyl-6-Oxo6,7-Dihydro-5H-Pyrrolo[2,3-D]Pyrimidin-5-Yl}Phenyl)Propanoic Acid
Sponsor:Merck Sharp & Dohme LLC

Contact Research Centre

Substances studied in this area

The therapies tested most often in Respiratory, thoracic and mediastinal disorders trials.

Carboplatin168 clinical trials Pembrolizumab143 clinical trials Cisplatin127 clinical trials Pemetrexed108 clinical trials Paclitaxel80 clinical trials Durvalumab71 clinical trials Atezolizumab50 clinical trials Sodium Chloride49 clinical trials Nivolumab48 clinical trials

Respiratory, thoracic and mediastinal disorders – page 100

Conditions in this area

Clinical trials in Respiratory, thoracic and mediastinal disorders

1 274 clinical trials

Lung disorder

Study on Baricitinib for Hospitalized Patients with Severe or Critical COVID-19

Lung disorder

Study on the Effectiveness and Safety of Bemcentinib for Hospitalized Patients with Moderate COVID-19

COVID-19

Study on Pamapimod and Pioglitazone for COVID-19 Recovery in Non-Hospitalized Patients

Chronic obstructive pulmonary disease

Study on Reducing Inhaled Corticosteroids and Using Azithromycin for Patients with Severe COPD

Asthma

Study on Asthma Control and Adherence with Mepolizumab in Pre-filled Devices for Patients with Asthma

Non-small cell lung cancer

Study on Re-Challenging Advanced Lung Cancer with Cemiplimab After Initial Treatment with Ipilimumab and Radiotherapy

Squamous cell carcinoma of head and neck+2

Study of BGB-A425, LBL-007, and Tislelizumab for Patients with Advanced Head and Neck Cancer, Lung Cancer, or Kidney Cancer

Atrial fibrillation+2

Study on Dabigatran, Apixaban, Rivaroxaban, and Edoxaban for Patients with Atrial Fibrillation, Deep Vein Thrombosis, or Pulmonary Embolism

COVID-19

Study on Antiviral Therapy with Nirmatrelvir and Remdesivir for Immunocompromised COVID-19 Patients

Pulmonary embolism+2

Study on Tinzaparin and Dalteparin for Patients with Venous Thromboembolism

Non-small cell lung cancer+3

Study on Calcium Folinate to Reduce Pemetrexed Side Effects in Patients with Non-Small Cell Lung Cancer, Mesothelioma, or Thymoma

Pulmonary hypertension

Study on the Safety and Effectiveness of MK-5475 for Adults with Pulmonary Hypertension and COPD

Filter the trials

Substances studied in this area

Prefer not to search? Our Concierge searches the trials for you.